Esketamine for treatment-resistant depression in adults - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cochrane Database of Systematic Reviews Année : 2022

Esketamine for treatment-resistant depression in adults

Résumé

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The main aim of this Cochrane review is to assess the efficacy and tolerability of esketamine for treatment-resistant depression. Secondary aims are to assess the risk of specific adverse events during esketamine treatment, and its acceptability. Copyright © 2022 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.

Dates et versions

hal-03632616 , version 1 (06-04-2022)

Identifiants

Citer

C. Gastaldon, P.F. Laurenzi, G. Schoretsanitis, D. Papola, I.A. Cristea, et al.. Esketamine for treatment-resistant depression in adults. Cochrane Database of Systematic Reviews, 2022, 2022 (1), pp.CD015071. ⟨10.1002/14651858.CD015071⟩. ⟨hal-03632616⟩
59 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More